Grade B
Rct
Featured
Meditation and Anxiety: 8-Week MBSR Outcomes
Randomized trial comparing 8-week Mindfulness-Based Stress Reduction to escitalopram for generalized anxiety disorder.
Published 2024
18 views
DOI: 10.1001/jamapsychiatry.2024.0251
[STUDY DETAILS]
- Study Type
- Rct
- Quality Grade
- B
- Publication Year
- 2024
- Category
- Mental Health & Cognition
Summary
RCT (n=276) found 8-week MBSR non-inferior to escitalopram for GAD. HAM-A scores improved 5.5 points with MBSR vs 5.9 with medication. MBSR had fewer side effects.
Key Findings
1. MBSR non-inferior to escitalopram
2. Anxiety reduction -5.5 points (HAM-A)
3. 78% response rate with MBSR
4. Fewer side effects than medication